investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Rab Geranylgeranylation: a Novel Therapeutic Target in Multiple Myeloma
Sarah A Holstein
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
No posts
Related projects
Robert Zygmunt Orlowski
Role of TJP1 in Sensitivity and Resistance to Proteasome Inhibitors in Myeloma
Multiple myeloma and immunoproliferative diseases
Teru Hideshima
Functional and biologic significance of deacetylase3 inhibition in myeloma
Multiple myeloma and immunoproliferative diseases
Kelvin P. Lee
CD28-mediated Regulation of Multiple Myeloma Cell Proliferation and Survival
Multiple myeloma and immunoproliferative diseases
Irene M. Ghobrial
The role of miRNA15a and 16-1 in Multiple Myeloma
Multiple myeloma and immunoproliferative diseases
Jing Yang
Targeting adipocyte-secreted chemerin for chemotherapy resistance in myeloma
Multiple myeloma and immunoproliferative diseases
Wei Gu
HAUSP inhibitors in p53-wild type and p53-mutant tumors
Multiple myeloma and immunoproliferative diseases
Irene M. Ghobrial
Stroma-mediated clonal evolution in Multiple Myeloma
Multiple myeloma and immunoproliferative diseases
Ruben D Carrasco
Validating the eCyPA/CD147 signaling complex for myeloma therapy
Multiple myeloma and immunoproliferative diseases
Hematology and hematologic malignancies
Daniel M Sullivan
CRM1 INHIBITORS SENSITIZE MULTIPLE MYELOMA CELLS TO TOPOISOMERASE II AND PROTEASOME INHIBITORS
Multiple myeloma and immunoproliferative diseases
